Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Review ArticleExperimental Studies

HER-2 and NF-κB as the Targets for Therapy-resistant Breast Cancer

KAZI M. AHMED, NING CAO and JIAN JIAN LI
Anticancer Research November 2006, 26 (6B) 4235-4243;
KAZI M. AHMED
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NING CAO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JIAN JIAN LI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jjli{at}purdue.edu
  • Article
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 26 no. 6B 4235-4243
PMID 
17201139

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received June 27, 2006
  • Accepted September 4, 2006
  • Published online November 1, 2006.

Copyright & Usage 
Copyright© 2006 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. KAZI M. AHMED,
  2. NING CAO and
  3. JIAN JIAN LI
  1. Division of Molecular Radiobiology, Purdue University School of Health Sciences, Purdue Cancer Center, West Lafayette, Indiana 47907, U.S.A.
  1. Correspondence to: Dr. Jian Jian Li, Ph.D., 1279 Civil Engineering Building, 550 Stadium Mall Drive, West Lafayette, Indiana 47907, U.S.A. Tel: 765-496-6792, Fax: 765-496-1377, e-mail: jjli{at}purdue.edu

Statistics from Altmetric.com

Cited By...

  • 60 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 26, Issue 6B
November-December 2006
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
HER-2 and NF-κB as the Targets for Therapy-resistant Breast Cancer
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 4 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
HER-2 and NF-κB as the Targets for Therapy-resistant Breast Cancer
KAZI M. AHMED, NING CAO, JIAN JIAN LI
Anticancer Research Nov 2006, 26 (6B) 4235-4243;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
HER-2 and NF-κB as the Targets for Therapy-resistant Breast Cancer
KAZI M. AHMED, NING CAO, JIAN JIAN LI
Anticancer Research Nov 2006, 26 (6B) 4235-4243;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Targeting PSG1 to enhance chemotherapeutic efficacy: new application for anti-coagulant the dicumarol
  • Amentoflavone Induces Anti-angiogenic and Anti-metastatic Effects Through Suppression of NF-{kappa}B Activation in MCF-7 cells
  • Chemotherapeutic Properties of Phospho-Nonsteroidal Anti-Inflammatory Drugs, a New Class of Anticancer Compounds
  • Direct Inhibition of Elastase Activity by Indole-3-Carbinol Triggers a CD40-TRAF Regulatory Cascade That Disrupts NF-{kappa}B Transcriptional Activity in Human Breast Cancer Cells
  • Noninvasive Bioluminescent and MicroPET Imaging for the Regulation of NF-{kappa}B in Human Hepatoma-bearing Mice
  • Google Scholar

More in this TOC Section

  • Integrative Analysis Combining Machine Learning and Functional Experiments Uncovers ISG15 As a Key Determinant of Cisplatin Resistance in Gastric Cancer
  • Allow Aloe to Do the Work: Aloe vera Constrains Growth of Bladder Cancer Cells and Modulates Expression of Key Costimulatory Molecules
  • PKF118-310 as a Potential Small Molecule Inhibitor Targeting the Wnt/β-Catenin Pathway for Gastric Cancer Therapy
Show more Experimental Studies
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire